Masoud Hafizi 1
, Maryam Khosravian 2
, Payam Peymani 3
, Shahrzad Alimohammadi 4,5
, Shokouh Shayanpour 6*
, Hamid Reza Jahantigh 7 1
Department of Infectious Diseases, Shahrekord University of Medical Sciences, Shahrekord, Iran2
Clinic for Internal Medicine I, Martin-Luther University Halle/Wittenberg, Ernst-Grube-Straße 40, D 06120 Halle, Germany3
Rady Faculty of Health Sciences, College of Pharmacy, University of Manitoba, 750 McDermot Avenue, Winnipeg, MB R3E 0T5, Canada4
Doctoral School of Molecular Medicine, University of Debrecen, Debrecen, Hungary5
Department of Immunology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary6
Chronic Renal Failure Research Center, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran7
Department of Pathology, Faculty of Medicine, Emory University, Atlanta, GA, USA
Immunoglobulin A (IgA) nephropathy is the most common type of glomerulonephritis worldwide characterized by excessive serum levels of glycosylated which triggers the generation of glycan-specific IgG and IgA autoantibodies. This pathological condition results in the formation of circulatory IgA immune complexes, which are essential for the development of glomerular inflammation, especially IgA nephropathy. The serum galactosylated IgA1, IgG, and IgA autoantibodies are suggested as the biomarkers of IgA nephropathy since IgA antibodies are early markers for disease activity too. Serum IgA antibodies emerged as the early COVID-19-specific antibody response about two days after initial symptoms of COVID-19 in comparison with IgG and IgM antibody concentrations, which appeared after five days. IgA nephropathy is frequently presented as microscopic or macroscopic hematuria and proteinuria with a male predominance. COVID-19 infection can include several organs aside from the lungs, such as kidneys through different mechanisms. It is demonstrated in most cases that short-lasting symptoms such as gross hematuria resolve either spontaneously or following a short course of steroids. This review summarized the reported cases of relapses or denovo reported cases of relapses or de-novo IgA nephropathy and IgA vasculitis following COVID-19 vaccination.
Implication for health policy/practice/research/medical education:
Some case reports emphasize COVID-19 vaccination can aggravate pre-existing occult, un-diagnosed and known kidney diseases such as IgA nephropathy with significant clinical flares as kidney dysfunctions. Therefore, the recognition of autoimmune diseases flare following COVID-19 vaccination is important to improve our knowledge on the diagnosis and control of acute post-vaccination complications.
Please cite this paper as: Hafizi M, Khosravian M, Peymani P, Alimohammadi S, Shayanpour S, Jahantigh HR. Relapses or de-novo IgA nephropathy following COVID-19 vaccination; a narrative review. J Nephropathol. 2023;12(2):e21438. DOI: 10.34172/jnp.2023.21438.